Try our Advanced Search for more refined results
Life Sciences - June, 2022
308 articles
- We're Not All Textualists Now, Kagan Warns In Climate Dissent
- SF Says Pharmaceutical Cos. Created City's Opioid Crisis
- Opioid Distributors Headed To 2nd W.Va. Nuisance Trial
- Justices Stoke Care Woes For Tribes, Native Women Post-Roe
- Justices' Patent Eligibility Denial Won't End Fight For Clarity
- Endo 'Made Out Like A Bandit' With Opana Deal, Buyers Say
- Thomas Dissents On Denial Of NY Health Worker Vax Case
- IP Forecast: Apple Foe Looks To Revive Axed $308M Verdict
- Juul Buyers Win Cert. For 4 Classes In Vape MDL
- Gov't Contracts Of The Month: Space, Nuclear And Drug Deals
- No Stick In Dollar General's Pain Relief Patches, Suit Says
- Pa. Co. Says Distributor Lied To Land $5.5M COVID Test Deal
- Ex-Mich. Gov. Pleads 5th In Flint Trial Appearance
- 3 Firms Help Blueprint Medicine Get $1.25B Investment
- HHS Issues Guidance On Abortion Patient Privacy After Dobbs
- In COVID, Can PREP Act Protection Extend To Patent Suits?
- Ethics Considerations For Attorneys Joining Nonprofit Boards
- Fla. Judge Says 15-Week Abortion Ban Is Unconstitutional
- Ohio AG Says 6-Week Abortion Ban Should Remain In Place
- Ex-Mich. Gov. Claims No Memory On Aspects Of Flint Crisis
- Juul Says Politics Drove FDA Ban, Seeks To Extend Stay
- Fla. Physical Therapy Clinic Workers Sentenced For Fraud
- NJ Lawmakers Pass Post-Dobbs Abortion Rights Measures
- Review Of Emergent's $325M Smallpox Drug Deal Extended
- High Court's Opioid Ruling Shows Limits Of CSA's Reach
- HHS Watchdog Sees Kickback Concern In Eye Care Programs
- Private Hospital Deal Challenge Best Left To Feds, Judge Says
- Ireland Examinership Becoming Critical In Int'l Insolvency
- What Maine's Recent PFAS Crackdown Means For Companies
- Arch Finalizes $3B Fund To Spur Revolutionary Technology
- Change Could Be Coming To Patent Suit Volume In Texas
- The State Of Abortion Legal Challenges Around The US
- Ohio Abortion Clinics Turn To State High Court After Dobbs
- Texas AG Investigates Walmart's Opioid Sales Practices
- High Court's CSA Decree Augurs Opioid Upheaval For DOJ
- Flint Jury To Hear From Ex-Gov. After Court Quashes Charges
- 6th Circ. Lifts Block On Tenn. Abortion Restriction
- USPTO Issues Report On Patent Eligibility Comments
- 2nd Circ. Ruling Highlights ERISA Determination Deadlines
- Becerra Says 'All Options Are On The Table' After Dobbs
- Recent Trade Secret Cases Show Sentencing Disparities
- Chancery Urged To Consider Firms' Bid To Lead Ionis Suit
- Warby Parker Escapes 1-800 Contacts' Search Engine TM Row
- Alcon Eye-Drop Patents Survive Invalidity Appeal
- Texas Judge Freezes Enforcement Of Pre-Roe Abortion Ban
- As Opioid Trial Ends, Judge Jokes Of 'Generous' Time Limits
- Opioid Distributors Cut $250M Deal With Holdout Okla. AG
- Balwani's Trial Features Tears, Tension And Holmes' Shadow
- Cannabis Bill Roundup: NJ Sen. Eyes Legalizing Hallucinogen
- Catching Up With Delaware's Chancery Court
- Justices Should Resolve FCA Cases' Rule 9(b) Circuit Split
- Ditching Live Testimony For Declarations Is Risky, Attys Say
- Humana Wants To Add Federal Antitrust Claims To Zetia Case
- Trade Secret Suit Over Anesthetic's Cocaine Ingredient Settled
- Supreme Court Won't Review Vascepa Patent Case
- Nomad Health Raises $105M To Grow Traveling Jobs Program
- Utah, Louisiana Abortion Bans Blocked, For Now
- High Court Won't Hear $87M Monsanto Roundup Appeal
- Justices Won't Hear Anthem, Express Scripts Drug Price Fight
- Prescriber Intent Matters In Opioid Cases, High Court Rules
- CareTech To Be Taken Over By Founders In £870M Deal
- Calif. Bank & Trust To Pay $14M To End Claims It Aided Scam
- Abortion Questions Swirl Over Health Attys In Post-Roe World
- Bristol-Myers Can't Dodge Celgene Investors' Drug Delay Suit
- Judge Won't Lift Stay In Masimo Patent Fight Against Apple
- Joint Juice Slams 'Staggering' $141M Ask For False Ad Verdict
- 'Trust Your Eyes,' Feds Urge As Balwani Charges Go To Jury
- NH Medical Society Denounces Insurers' COVID-19 Science
- Dr. Reddy's Gets $72M In Generic Suboxone Settlement
- Juul Wants Okla. Tribe's Nuisance, Product Safety Claims Cut
- Retailers Cut Midtrial Deal With Impax In Opana Delay Case
- Beware Arbitration Clauses That May Bar Inter Partes Review
- Gov't Gets 30 More Days To Review China Tariff Comments
- 3rd Judge On NYC Vax Case Refuses To Step Down
- Health Hires: Arnold & Porter, Arcellx
- Now's The Time To Address Archaic Law School Curricula
- DC Circ. Blocks Enforcement Of FDA's Juul Vape Ban
- The Case For Company-Directed Offensive ESG Litigation
- Supreme Court Overturns Roe v. Wade
- Balwani Rips Feds' 'Incomplete' Case As Trial Nears End
- The Attys Who Took America To Abortion Rights Turning Point
- Pot Advocates Ask 8th Circ. To Put Neb. Election Law On Ice
- Orrick Hires 2 Trial Attys From BakerHostetler
- Lawmakers Warn DOJ Of Brewing Baby Formula-PE Deal
- 3 Firms Usher Radius Health Off Public Market In $890M Deal
- PTAB Refuses Post-Grant Reviews Of 2 Psilocybin Patents
- Abbott Must Face Suit Over Anticonvulsant Birth Defect Risks
- The Unique Nature Of COVID-Era Patent Procurement Trends
- Cyprus Mines Wins Ch. 11 Stay Of Actions Against Parent
- F-Star Therapeutics Agrees To $161M Sino Biopharm Takeover
- FDA Orders Juul E-Cigs Off Shelves
- Lessons From Lawyer Fee-Sharing Agreements Gone Wrong
- Crowell & Moring Adds Stein Mitchell Health Care Litigator
- Balwani's Atty Tells Jury Romance With Holmes Not A Crime
- Ex-Pharma Exec Cops To Insider Trading With Former CFO
- PTAB Nixes Patent Claims For Device To Measure Blood Clots
- Pharmacies' Surescripts Antitrust Case Survives Dismissal
- LeClairRyan Bankruptcy Highlights Pass-Through Tax Issue
- SuperValu Urges High Court Not To Revive FCA Case
- DOJ Official Confirms CCO Certs. Are New Settlement Staple
- 2nd Circ. Got High Court Order Right, Chinese Exporters Say
- Imerys, Cyprus Don't Need To Share Docs With Insurers
- Robbins Geller Seeks Third Of $15M OvaScience Settlement
- Kirkland Guides PE Firm's £650M Acquisition Of Lab Tech Co.
- Fed. Circ. Reverses Initial Panel To Find Gilenya IP Invalid
- Feds Portray Balwani As Holmes' Partner In Crime In Closings
- FDA Seeks To Cap Cigarettes' Nicotine Content
- New Bill Would Create Joint USPTO-FDA Task Force
- Judge Approves $45M Roundup False Ad Deal
- Philips Knew Of CPAP Foam Issues In 2015, Device Users Say
- Potential Next Steps For DOJ's COVID-19 Fraud Enforcement
- Medical Imaging Co. Says Swiss Award Was Marred By Fraud
- Revlon Case Opens, And LATAM Lands Its Ch. 11 Plan
- 8 Steps To Creating A Legal Ops Technology Road Map
- 20 States Ask 5th Circ. To Block Biden's Contractor Vax Order
- Importers, USTR Wrestle Over Deadline In China Tariff Case
- Catching Up With Delaware's Chancery Court
- High Court Won't Review $25M Monsanto Roundup Verdict
- The Law360 400: Tracking The Largest US Law Firms
- Will BigLaw Regret Its Hiring Spree As The Economy Softens?
- FDA Greenlights Moderna, Pfizer Jabs For Kids 6 Mos. And Up
- WTO Vax Patent Deal Seen As Doing Little To Boost Access
- Bayer Notches 4th Trial Win Over Roundup Weedkiller
- Fintiv Denials Are Down, But Bill Banning Them Still Has Teeth
- Teligent's Post-Sale Drug Recall Puts Its Ch. 11 Plan In Doubt
- Generic Co. Asks Fed. Circ. To Undo Loss In Takeda IP Fight
- Clarivate Atty Joins Pharma Intelligence As GC
- 6 Firms Guide UK Biotech Startup's $215M SPAC Merger
- WTO Inks Deals On Fisheries, Vaccines After Lengthy Session
- Yale Law Prof Defends Allergan In SF Opioid Trial
- Chevron Deference Still Feels Heat After High Court Reprieve
- Del. Justices Uphold Toss Of Zimmer Biomet Stockholder Suit
- IP Forecast: Cooley To Fight DQ Bid In Tech Patent Row
- 4th Circ. Denies Eli Lilly's Discovery Bid In Novartis IP Feud
- Pa. Court Halts Recall Of Cannabis Vape Products
- Biogen Urges Justices To Review MS Drug Patent Ruling
- Stimwave Gets OK To Tap $12M In Bankruptcy Financing
- FTC Warns Drugmakers, Middlemen Over Rebates
- The Importance Of Data And Data Analysis In Litigation
- Why Medical Product Cos. Must Watch Dobbs Decision
- Aetna Urges 1st Circ. To Toss Conformis Defamation Suit
- It's Time For USPTO To Abandon The NHK-Fintiv Practice
- Insurer Loses Bid To Limit Boston Hotel's Virus Losses
- $60M Catalyst Sale Gutted Company, Del. Investor Suit Says
- Ark. Prof Gets 1 Year For Lying To FBI About China Patents
- CVS Can't Force Drug Pricing Suit Into Arbitration
- Foley & Lardner Atty Joins Network Health As CLO
- Rising Star: Ropes & Gray's Emily Oldshue
- SF Opioid Crisis Not From Allergan's Market Share, Judge Told
- J&J Keeps Victory Over Defective Mesh Claims At 7th Circ.
- DaVita Must Return Rather Than Destroy No-Poach Docs
- Insurers Should Pay For Medical Pot In New Mexico, Suit Says
- Novartis Can't Keep Bristol-Myers Arbitral Award Under Wraps
- Zydus Blasts Takeda's Patent Abuse 'Blueprint' At 3rd Circ.
- CBD Cos. Must Beware COVID Claims Amid Gov't Scrutiny
- Fla. Medical Device Co. Hits Ch. 11 Amid Ex-CEO Litigation
- Objector Tells 11th Circ. Atty Fees Too High In $8M Class Deal
- FDA Panel Backs Moderna, Pfizer Vaccines For Young Kids
- Biotech Farming SPAC Merger Creates $504M Public Co.
- Judge Trims CEO's Bonus Pay At His Last Purdue Hearing
- Feds Hit Nursing Home With FCA Suit Over 'Nonexistent' Care
- Rising Star: Goodwin Procter's William D. Collins
- Wilson Sonsini Adds Cooley Lateral In New Boulder Office
- WTO Summit Extended Amid A Scramble For Consensus
- High Court Rejects Medicare's $1.6B Cut To Hospital Drug Pay
- Fla. Pharmacy Owner Gets 14-Year Sentence For Mail Fraud
- SF Opioid Judge Not 'Sympathetic' To City's Scheduling Issue
- 'Huge Problem': FDA Leaders Fear Collapsing Trust In Agency
- Bristol-Myers Urges Justices To Ax 'Impossible' Patent Rule
- Impax Got Earliest Possible Generic Opana Entry, Jury Hears
- 'It's Time To Rethink Everything,' Vidal Says
- Kentucky Gov. Creates Medical Cannabis Advisory Group
- NY Panel Upholds Botanical Garden's Virus Coverage Win
- 8th Circ. Won't Revive Suit Over Surgical Tool IP
- Remand Denial Raises Question In W.Va. Opiate Litigation
- Bristol-Myers Sues To Block Rival's Generic Leukemia Drug
- J&J Talc Unit Wants Ch. 11 Claims Estimation Process
- 5th Circ. Affirms Toss Of Hospital Workers' Vax Mandate Suit
- Judge OKs Email Service Of Law Firms In Cyprus Mines Suit
- Ice Miller Adds 4-Attorney IP Team From BakerHostetler
- Steps Companies Can Take To Mitigate Privilege Labeling Risk
- Rising Star: DLA Piper's Jessica Wilson
- Amarin Beats Class Claims Of Duping Investors At 3rd Circ.
- Judge Breyer Pitches Law Chat As SF Opioid Trial Nears End
- Ohio Counties Open To Lowering Opioid Damages Request
- Investor Attys Net $22.6M In Dental Supply Antitrust Deal
- Pharma Co. Exec's Wife Inks SEC Deal Over Insider Trading
- GOP Rep. Stokes China Fears Amid COVID IP Waiver Talks
- Takeda Unit Warns Fed. Circ. Antibody Patents At Risk
- NY AG's Opioid Trial Theory Fatally Flawed, Teva Says
- Blade Therapeutics' $353M SPAC Go-Public Deal Called Off
- Texas Judge Won't Toss Vineyards' Suit Against Bayer, BASF
- Catching Up With Delaware's Chancery Court
- Fed. Circ. Revives UMass Skin Care IP Suit Against L'Oreal
- Judge Exits NYC Vaccine Case After Stock Complaints
- Ex-Moderna Public Policy VP Rejoins Epstein Becker
- Hemp Equipment Co. Fights Bid To Ditch Counterclaims
- Labcorp Accused Of Bias Over Medical Pot In Job Drug Test
- Rising Star: Butler Snow's Susanna Moldoveanu
- Justices Spurn Insys Exec's Appeal In Landmark Opioid Case
- US Taking Long View On Reshaping WTO As Summit Opens
- Opioid Judge Disavows 'Unfair' Atty Fees But Still Draws Fire
- GoodRx Investors' Claims Over IPO Get Axed For Good
- 9th Circ. Mulls If Valid Patents Moot FCA Suit Against Bausch
- Fed. Circ. Eyes Eligibility Of Stanford's Transplant Testing IP
- States Get $853K In Pared Down Shkreli Antitrust Case Fees
- Bayer Notches 3rd Roundup Trial Win With Missouri Verdict
- Balwani Can't Get Jury Edge Over Lost Theranos Database
- Trader Pleads Guilty In Biotech Co. Stock Spoofing Scheme
- Sens. Urge Vidal To Block Drug Patent 'Thickets' Early
- What Litigation Funding Disclosure In Delaware May Look Like
- Zymeworks Takes Poison Pill To Block Hostile Bid
- NYC Teachers Want Judge Off Vax Case Due To Pfizer Stock
- Del. Court Denies Ex-CEO GenapSys Committee Access
- How To Avert Unlawful Poaching Amid Rising Antitrust Risks
- State Crackdown On Deceptive Ads For Drug Suits Is Welcome
- Rising Star: Baker McKenzie's Khelin Aiken
- Hogan Lovells Adds Foley Hoag M&A Co-Chair In Boston
- IP Forecast: '60 Seconds' Car Copyright Saga Rolls Into LA
- Balwani Rests After Testimony On Lost Theranos Database
- FTC Eyes Drugmaker Rebates Boosting Higher Cost Drugs
- Shipping Co. Wants Suit Over $200M Accident Award Nixed
- FDA Answers Hair Loss Drug Petition, Group Drops Suit
- Jury Clears Reckitt Benckiser In Trade Secret, Fraud Trial
- FTC Judge Says Lives At Stake In Cancer Test Deal Challenge
- FDA Medical Device Cyber Guidance Protects Patients, Cos.
- Ex-Illumina CPA Ducks Prison After Insider-Trading Testimony
- Reed Smith Litigator Joins Jackson Walker In Houston
- Tech Pro Becomes Latest Perkins Coie Atty To Jump To MoFo
- Drug Industry Didn't Create Nation's Opioid Crisis, Judge Told
- FTC Probe Into Rx Middlemen May Spark Industry Shakeup
- Costlier Loans Clear Mallinckrodt For Ch. 11 Exit Next Week
- Blood Plasma Co.'s $10M BIPA Deal Gets Early Blessing
- Cyprus Sues In Del. Ch. 11 To Block 'Alter Ego' Talc Suits
- Fed. Circ. Affirms PTAB Ax Of Omni MedSci IP In Apple Row
- Medtronic Hernia Mesh Suits Transferred To Mass. By JPML
- Amgen, Juno And The Fate Of Functional Genus Claims
- Hartford Must Pay Medline Legal Fees To End Federal Case
- Joint Juice Hit With $1.49M NY Class False Ad Verdict
- Rimon Opens Orlando Office With Life Science Atty
- DEA Change In Opioid Policy Created Confusion, Judge Hears
- Don't Trust DOJ's 'Pure Ipse Dixit' On FCA Split, Justices Told
- AGs' Disgorgement Claim Axed In Drug Price-Fixing Case
- DEA Says Pot Researchers' Suit Belongs In Circ. Court
- Tivity Investors Win Cert. In Suit Over $1.3B Nutrisystem Deal
- FDA Chafes At Drugmaker's Graphic Design In Promo Piece
- Mylan Takes Actelion Drug IP Fight To Fed. Circ.
- FTC To Probe Pharma Middlemen Over High Drug Prices
- WTO Leaders Make Push For Deals Ahead Of Summit
- Wis. Judge Blocks Tribal Court Opioid Suit Against McKinsey
- Merck General Counsel Added To Biotech Company's Board
- 2nd Circ. Gives Salesman Another Shot At Hartford ERISA Suit
- FDA Panel Backs Novavax's COVID-19 Vaccine
- Goodwin Boosts DC Litigation Team With False Claims Act Pro
- Ex-Eli Lilly Worker Sues Over 'Serious' Manufacturing Issues
- GW Pharma Wants Judge To Nix Investor Suit Over $7.2B Deal
- 3rd Juror Sick As Balwani Trial Nears End Without Holmes
- Bristol-Myers Inks $10.8M Deal In Direct Buyers' Antitrust Suit
- Catching Up With Delaware's Chancery Court
- 5th Circ. Doubts Requests For Health Care Vax Opinion
- Understanding FDA's Prescription Drug Promotion Priorities
- 9th Circ. Securities Fraud Ruling Bodes Well For Pharma Cos.
- Taking A Long-Term View On Russia's Patent Landscape
- 5th Circ. Mulls Sending Hospital Vax Suit To Texas Justices
- Moderna Can't Punt To Gov't In COVID-19 Vax Suit, Cos. Say
- How In-House Legal Leaders Can Drive Corporate Growth
- McKesson Seeks Early Appeal In Opioid Coverage Dispute
- Chancery Stays Suit Over Drug Trial Disclosure Failures
- Simpson Thacher Adds Goodwin Securities Pro In Palo Alto
- The Future Of Legal Cannabis In The Nation's Capital
- A Look At Public's Divergent Views On New Merger Guidelines
- Zoetis Must Face Suit Over Horse's Death From Antibiotics
- Ropes & Gray, Goodwin Steer $1.5B Pharmacy Tech Co. Deal
- Illumina Wants 'Indefensible' $334M DNA IP Verdict Tossed
- Del. Judge Recommends Keeping Blood Analyzer IP Row Alive
- Chancery Tosses Remainder Of Suit Against Vaccine Firm
- Nostrum Loses Asthma Drug FDA Fight At DC Circ.
- Wash. High Court Says Drugmakers Need Not Warn Patients
- NY Cop Sues City Over Vax Mandate That Exempts Athletes
- HHS' Free Genetic Testing Opinion Raises Questions For Cos.
- Attorneys Should Tread Carefully On Job Counteroffers
- Ex-Quest Workers Seek Cert. In ERISA Class Action
- Kirkland, Cooley Pilot Bristol-Myers' $4B Cancer Drug Co. Buy
- Walgreens Exec Faces Tough Queries From SF Opioid Judge
- Panel Rejects Opioid MDL Expansion Despite 'Flood Of Cases'
- Insider Trading Claims In Sanofi-Bioverativ Suit Move Forward
- PTAB Axes 2 Masimo Corp. Patents Involved In Apple Row
- Goodwin To Pay BioDelivery $850K To Settle Shareholder Suit
- No Atty Fees For Lionbridge After Trade Secrets Win
- 'Overzealous' Claim Not Enough To Redo Teva NY Opioid Trial
- The Future Of Legal Ops: Time To Get Serious About Data
- Conn. Atty Wins New SEC Trial After Judge's Jury Poll Gaffe
- SF Opioid Judge Told Higher Doses Increased Addiction
- Sidley Not Conflicted, NJ Diocese Ch. 11 Moves Forward
- Pfizer Attacks Rival's Claims Over Vaccine Patent In Del.
- Fla. Abortion Providers Sue State Over 15-Week Ban
- Conn. Atty Can't Flip Fraud Verdict Over Jury Instructions
- Precigen Investors' Gas Fraud Suit Gets Axed, For Now
- Pot Co. Aphria Urges Judge To Deny Investors' Class Cert. Bid
- Zydus Defeats 209-Patient Suit Over Heart Pill Marketing
- 5 Observations On Solicitor General's Patent Eligibility Brief
- Calif. Panel Reverses Zimmer's $7.7M Hip Implant Retrial Loss
- Synthego Gets PTAB To Review 2 Full CRISPR Patents
- Cannabis Research Lab Pushes Back On DEA Bid To Toss Suit
- Insight Into California's Increasing Cannabis Litigation
- Examiner Gets $950K In Fee Cuts In J&J Talc Unit's Ch. 11
- Dobbs Draft Hints At Bold Court With Harvard Case On Deck
- SF Opioid Judge Irked At Allergan Argument Against Expert